If you are an investor in Applied Therapeutics and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (212) ...

A class action lawsuit was filed against Applied Therapeutics, Inc. (APLT) by Levi & Korsinsky on December 17, 2024. The ...

New York, New York-- (Newsfile Corp. - February 11, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Applied Therapeutics, Inc. (NASDAQ: ...

including Classic Galactosemia, Sorbitol Dehydrogenase (SORD) Deficiency and PMM2-congenital disorder glycosylation (CDG).

The Company’s lead drug candidate, govorestat, is a central nervous system penetrant Aldose Reductase Inhibitor for the treatment of CNS rare metabolic diseases, including Galactosemia.

Iremide Kasali, a 5-year-old girl, came into the world with cataract, but her parents did not come to terms with the condition early enough.

The outcome of the review has come as a major disappointment for patients and their families, with the Galactosemia Foundation calling the outcome "devastating" and urging the FDA to "reconsider ...

Galactosemia, Phenylketonuria, Gaucher Disease, Pompe Disease, Fabry Disease, MPS II (Hunter Syndrome), MPS IV (Morquio Syndrome), and Osteogenesis Imperfecta preventive oral health services to ...

Besides these, medical conditions such as galactosemia and cystic fibrosis can impair the body’s ability to produce energy from food or hinder energy absorption, causing slow or no weight gain.